[
  {
    "ts": null,
    "headline": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
    "summary": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=58f8b45671ca774e7478961248e9c6249e3c5543f2e22dd295074ddcb3459a6a",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740069420,
      "headline": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
      "id": 132837855,
      "image": "",
      "related": "GILD",
      "source": "MarketWatch",
      "summary": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=58f8b45671ca774e7478961248e9c6249e3c5543f2e22dd295074ddcb3459a6a"
    }
  },
  {
    "ts": null,
    "headline": "Gilead’s Seladelpar Granted Conditional European Marketing Authorization for the Treatment of Primary Biliary Cholangitis",
    "summary": "– Now Approved, Seladelpar Can Provide an Important Treatment Option for People Living With the Rare Liver Disease in the European Economic Area –– First and Only Treatment That Achieved...",
    "url": "https://finnhub.io/api/news?id=006216ccb6f3d440e6234ccd0e4d394fbb5a9230ce233f7ea79811fd95359852",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740069183,
      "headline": "Gilead’s Seladelpar Granted Conditional European Marketing Authorization for the Treatment of Primary Biliary Cholangitis",
      "id": 132823335,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "– Now Approved, Seladelpar Can Provide an Important Treatment Option for People Living With the Rare Liver Disease in the European Economic Area –– First and Only Treatment That Achieved...",
      "url": "https://finnhub.io/api/news?id=006216ccb6f3d440e6234ccd0e4d394fbb5a9230ce233f7ea79811fd95359852"
    }
  },
  {
    "ts": null,
    "headline": "Disount To Net Cash For A Promising CAR-T Company",
    "summary": "Galapagos NVâs split could unlock value despite short-term share decline. Learn why GLPG stockâs strategic focus offers upside but risks in the CAR-T space.",
    "url": "https://finnhub.io/api/news?id=1b2940149a0d46e5537bee9d1b0731550bb1593ad000bae24053a8c21939af84",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740035620,
      "headline": "Disount To Net Cash For A Promising CAR-T Company",
      "id": 132798424,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/525231584/image_525231584.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Galapagos NVâs split could unlock value despite short-term share decline. Learn why GLPG stockâs strategic focus offers upside but risks in the CAR-T space.",
      "url": "https://finnhub.io/api/news?id=1b2940149a0d46e5537bee9d1b0731550bb1593ad000bae24053a8c21939af84"
    }
  }
]